M.D. Anderson Cancer Center: all 3,044 studies

Page 31 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic LeukemiaWithdrawnNCT00006090Phase 2
• Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerCompletedNCT00006081Phase 2
• Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial NeoplasiaCompletedNCT00006079Phase 2
• Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerCompletedNCT00005991Phase 2
• Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's DiseaseWithdrawnNCT00005969Phase 2
• Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005092Phase 1
• SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the LiverWithdrawnNCT00005030Phase 1
• Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00004263Phase 1
• Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or LarynxCompletedNCT00004246Phase 1
• Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder CancerCompletedNCT00004154Phase 3
• Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverCompletedNCT00004142Phase 2
• Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver CancerCompletedNCT00004136Phase 2
• Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue SarcomaCompletedNCT00004123Phase 1
• Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue SarcomaCompletedNCT00004109Phase 1
• Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney CancerWithdrawnNCT00003714Phase 2
• Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedNCT00003693Phase 1
• Dolastatin 10 in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00003677Phase 2
• Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung CancerWithdrawnNCT00003599Phase 3
• Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant GliomasWithdrawnNCT00003564Phase 3
• Irofulven in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003441Phase 2
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00003311Phase 2
• Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaCompletedNCT00003245Phase 2
• Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00003239Phase 2
• Chemoprevention Therapy Plus Surgery in Treating Women With Breast CancerCompletedNCT00003099Phase 2
• Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate CancerCompletedNCT00003084Phase 2
• Fenretinide in Treating Patients With Cervical NeoplasiaCompletedNCT00003075Phase 3
• Amifostine in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003048Phase 2
• Interleukin-12 in Treating Patients With Cancer in the AbdomenCompletedNCT00003046Phase 1
• Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant MeningiomasCompletedNCT00002965Phase 2
• Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With MelanomaCompletedNCT00002882Phase 3
• Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerCompletedNCT00002855Phase 3
• Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00002844Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic LeukemiaCompletedNCT00002838Phase 1/2
• High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast CancerCompletedNCT00002837Phase 1/2
• Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast CancerCompletedNCT00002836Phase 3
• Combination Chemotherapy in Treating Patients With LymphomaCompletedNCT00002835Phase 3
• Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaCompletedNCT00002833Phase 2
• Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedNCT00002832Phase 1/2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute LeukemiaCompletedNCT00002831Phase 1/2
• Bone Marrow Transplantation in Treating Patients With LymphomaCompletedNCT00002829Phase 2
• Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the StomachCompletedNCT00002682Phase 2
• Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's LymphomaCompletedNCT00002565Phase 3
• Combination Chemotherapy in Treating Patients With AIDS-Related LymphomaCompletedNCT00002524Phase 2
• Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal TumorsCompletedNCT00002463Phase 2

← M.D. Anderson Cancer Center overview and focus areas